
Hi guys, I am looking at stocks that fit a few criteria,
1. Below book value
2. Increase in EPS
3. PE below 15
4. Issue Dividend
With this four criterias, Only a few companies are listed and i will be doing some instant screening on them.
This is the result.
Haw Par Corporation Ltd.
Its price is relatively high now with a PE of 14+, but it is below book value by 11%.
Very healthy balance sheet and reasonable profit. There is a sharp decline of profit from 150m last year to 78m this year. Prior to the last 6 years, its profit is rising consistently.
They have 2 core operation, medication and leisure.
Medication would be the Tiger brand. Your medical sticker and cream. Leisure would be underwater would in singapore, pattaya and chengdu. Haw par villa also under them.
They dabble heavily into investment also, which caused the severe drop in profit.
Upon furthur research, their increase in profit is not due to their core operation. Core operation remains stagnant and they focus alot of time in investment. Obviously, they have poor marketing. >_<
Reccomended by stock analyst to buy. But i don't really reccomend it due to lack of economic moat and lack of focus by management. Currently, its price is trading at $5.9.
Tye Soon Limited
PB of 0.5562 and PE of 11.6580. Seems like there is a 45% MOS on the NAV. However, they made a huge lost of 6.1M in 2004 and only till 2007 did they break even that lost.
Didnt do any furthur research due to lousy earnings.
Time Watch Investments Ltd.
PE of 5.210, Lousy Earnings. Net profit margin is less than 7%
Hiap Moh Corporation Ltd
Dividend of 43.7975%
PE of 7.4151
PB of 0.6921
WAH! So high dividend and seems pretty undervalued! Lets look at the business and financials.
Aww... No wonder so hi dividend.. They delisted already..lol Akat..
-By Norman Yeo founder of private group investors Project zero






Comments: Ever since listed, their sales have been steadily increasing, almost 300million RMB every year. Net profit likewise also increases in tandem with sales. Operational cash flow remains healthy with the rate of receivables growth kept at minimal.
Comments: Due to the fact, the company has to plan for its future and sustain their competitiveness in the industry; A lower free cash flow (FCF) is seen. This was deal to more research and development cost. Recently in 2008, they spend a total of $600million RMB for the establishment of the new PMP production lines and expansion of current capacity. Profit margin remains very high and maintains at 36.8%-35% region.
Results from EPS growth model: Worth at least $0.80 per share if company is able to maintain an EPS of 0.10 per year for the next ten years.